{"anonymous": [], "male": [], "word_count": "554", "persons": null, "female": [], "pub_date": "2015-04-12T00:00:00Z", "subject": ["Chronic Traumatic Encephalopathy", "Football", "Brain", "Sports Injuries"], "organizations": ["Food and Drug Administration", "National Football League", "University of California, Los Angeles"], "news_desk": "Sports", "lead_paragraph": "Researchers at U.C.L.A. have been developing a biomarker that aims to identify tau protein deposits in the brain, a signature of C.T.E., when patients are given a PET scan.", "headline": {"main": "F.D.A. Warns Researchers on Claims of Drug to Detect Brain Disease", "print_headline": "Researchers Seeking to Find a Brain Disease in Living Patients Are Under F.D.A. Scrutiny"}, "snippet": "Researchers at U.C.L.A. have been developing a biomarker that aims to identify tau protein deposits in the brain, a signature of C.T.E., when patients are given a PET scan.", "subsection_name": "Pro Football", "_id": "552980b37988105c09d47908"}